Mycoplasma Details: NCBI 2093, gram-negative or unknown [genus]

| "Asterococcus" Borrel et al. 1910| "Asteromyces" Wroblewski 1931| "Borrelomyces" Turner 1935| "Bovimyces" Sabin 1941| "Pleuropneumonia" Tulasne and Brisou 1955| Asterococcus| Asteromyces| Borrelomyces| Bovimyces| Eperythrozoon| Eperythrozoon Schilling 1928 (Approved Lists 1980)| Haemobartonella| Haemobartonella Tyzzer and Weinman 1939 (Approved Lists 1980)| Mycoplasma| Mycoplasma Nowak 1929| Pleuropneumonia

  1. Respiratory Infections in Humans: Mycoplasma pneumoniae is a common species that can infect humans and cause respiratory infections. It is a significant cause of atypical pneumonia, particularly in children and young adults. Infections with M. pneumoniae may lead to symptoms such as cough, fever, and difficulty breathing.

  2. Urogenital Infections in Humans: Mycoplasma genitalium is associated with urogenital infections in humans, including urethritis and other sexually transmitted infections. It can cause symptoms such as urethral discharge and pain during urination.

  3. Joint and Systemic Infections: In addition to respiratory and urogenital infections, mycoplasmas have been implicated in joint infections, particularly in children. Mycoplasma infections may also be associated with systemic diseases, although their role in these conditions is not as well-defined.

  4. Animal Pathogens: Mycoplasmas are significant pathogens in animals, causing diseases in livestock and domesticated animals. For example, Mycoplasma gallisepticum can cause respiratory infections in birds, and Mycoplasma hyopneumoniae is associated with respiratory disease in pigs.

  5. Plant Pathogens: Some Mycoplasma species are plant pathogens, causing diseases in various crops. They are transmitted by insect vectors and can lead to conditions such as yellows and wilts in plants.

  6. Autoimmune Associations: Some studies have suggested a potential link between mycoplasma infections and the development or exacerbation of autoimmune conditions. The mechanisms involved are complex and not fully understood.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Mycoplasma

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 1.24 10 2910 0 1543 292 30 638.3 9 365 0 %ile 100 %ile
biomesight 78.12 0 90 30 130 0 284 88.1 60 100.1 20 160 8 %ile 90.7 %ile
thorne 100 9 141 0 129 49 25 40.7 9 121 0 %ile 100 %ile
thryve 70.76 0 64 21 147 0 3258 192.2 54 1564.1 2 172 12.1 %ile 90.1 %ile
ubiome 0.51 98 8702 0 10650 2394.5 389 4212 98 8702 16.7 %ile 66.7 %ile

External Reference Ranges for Mycoplasma

Mycoplasma (NCBI 2093) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 0 23.17 0 0.0023
Statistic by Lab Source for Mycoplasma
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 84.065 %   0.009 %  0.01 % 2490.0 2962
BiomeSightRdp 41.935 %   0.006 %  0.012 % 13.0 31
bugspeak 100 %   0.005 %  % 1.0 1
CerbaLab 66.667 %   0.003 %  0 % 2.0 3
custom 16.393 %   0.003 %  0.003 % 10.0 61
es-xenogene 17.241 %   0.078 %  0.063 % 5.0 29
Medivere 57.143 %   0.002 %  0.001 % 4.0 7
Microba 3.571 %   0.291 %  % 1.0 28
SequentiaBiotech 2.778 %   0.02 %  % 1.0 36
Thorne 86.139 %   0.003 %  0.003 % 87.0 101
Thryve 72.066 %   0.018 %  0.139 % 1001.0 1389
uBiome 0.505 %   0.239 %  0.421 % 4.0 792

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Antibiotics, Antivirals etc amoxicillin (antibiotic)s[CFS] 1 Studies recorded. The consensus is Decreases👶, Click for details.
Antibiotics, Antivirals etc erythromycin (antibiotic)s[CFS] 1 Studies recorded. The consensus is Decreases📓, Click for details.
Antibiotics, Antivirals etc fluoroquinolone (antibiotic)s 1 Studies recorded. The consensus is Decreases👶, Click for details.
Antibiotics, Antivirals etc ofloxacin (antibiotic)s 1 Studies recorded. The consensus is Decreases👶, Click for details.
Common Supplements Tributyrin 1 Studies recorded. The consensus is Increases👶, Click for details.
Diet Style Olive Oil 2 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) Far infrared Sauna 1 Studies recorded. The consensus is Decreases👶, Click for details.
Prescription - Other Streptococcus faecalis (Enterococcus faecalis) 1 Studies recorded. The consensus is Increases👶, Click for details.

Foods Containing the Mycoplasma bacteria

Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.

Sausage, Cyprus: Limassol Weight: 0.4879 Robiola di Roccaverano Cheese (Italy) Weight: 0.2669 Fermented glutinous rice Weight: 0.02796 Dehulled maize dough, Ghana Weight: 0.009969 yoghurt fermentation Weight: 0.008343 Mozzarella cheese Weight: 0.008295 Chinese fish sauce Weight: 0.005236 Sausage, Cyprus: Paphos Weight: 0.00469

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.